| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |